GO
Loading...

Baxter International Inc

More

  • Providing support was a renewed pledge by European Central Bank President Mario Draghi to keep monetary policy loose for an extended period to push inflation in the euro zone closer to the targeted two percent level.

  • Sept 24- Drug developer Merrimack Pharmaceuticals Inc said it would partner with Baxter International Inc to develop and market its pancreatic cancer drug outside the United States, sending its shares up as much as 27 percent premarket.

  • Providing support was a renewed pledge by European Central Bank President Mario Draghi to keep monetary policy loose for an extended period to push inflation in the euro zone closer to the targeted two percent level.

  • NEW YORK, Sept 24- Merrimack Pharmaceuticals shares were surging in premarket trade, up 24.5 percent to $8.95 after the company said it reached a deal to develop and market Merrimack's pancreatic cancer drug outside the U.S. with Baxter International.

  • Baxter to market Merrimack's cancer drug outside U.S. Wednesday, 24 Sep 2014 | 8:08 AM ET

    Sept 24- Drug developer Merrimack Pharmaceuticals Inc said it would partner with Baxter International Inc to develop and market its pancreatic cancer drug outside the United States, sending its shares up as much as 27 percent premarket.

  • Midday movers: Bank of America, eBay, 58.com & more Thursday, 21 Aug 2014 | 1:34 PM ET

    Some of Thursday's midday movers:

  • Aug 21- Baxter International Inc said a more potent version of its flagship blood disorder drug Advate met the main goal in a late-stage study.

  • US labs on standby to start work on Ebola drug Sunday, 10 Aug 2014 | 6:02 AM ET
    A nurse wears protective clothing as he demonstrates the facilities in place at the Royal Free Hospital in north London on August 6, 2014, in preparation for a patient testing positive for the Ebola virus.

    All three U.S. laboratories established to fight major public health threats say they are standing by to scale up a treatment for Ebola.

  • NEW YORK/ WASHINGTON, Aug 9- All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

  • Cramer: Dozens of stocks that could work higher Monday, 4 Aug 2014 | 6:56 PM ET

    Cramer likes to review the S&P 500’s Daily Action Charts in an effort to find stocks that could work higher.

  • The FDA, which had raised concerns that some patients developed antibodies to one component of the treatment, is not obliged to follow the advice of its advisory panels but typically does so. The FDA had asked whether certain subgroups of patients, such as pregnant women, should be excluded.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • UPDATE 1-Medical products boost Baxter's sales Thursday, 17 Jul 2014 | 8:33 AM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly earnings and revenue, helped by surging sales in its medical products division. Net adjusted income rose to $692 million, or $1.26 per share in the second quarter ended June 30, from $639 million, or $1.16 per share, a year earlier.

  • Here are safety plays for today's market, pros say Thursday, 10 Jul 2014 | 3:45 PM ET

    Two market pros explain where they are looking to make money in this market, and what names are on their buy list.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • *China launches anti-dumping probe into dialysis kit makers. SHANGHAI, June 13- China on Friday launched an anti-dumping investigation into makers of blood dialysis equipment in the European Union and Japan, including market leader Fresenius Medical Care AG& Co KGaA, challenging the international firms who currently dominate the global and Chinese markets.

  • Lightning Round: Bristol-Myers, Safeway & more Wednesday, 11 Jun 2014 | 6:50 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Citigroup, Veeva & More Monday, 2 Jun 2014 | 6:49 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • 3 firms unleashing big value: Cramer Monday, 14 Apr 2014 | 6:29 PM ET

    Jim Cramer says 3 companies are actively unlocking serious value right now.

  • Lightning Round: Citigroup, Disney & More Wednesday, 9 Apr 2014 | 6:45 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.